CSF2 and neoplasm: After replacing neurovirulence genes with granulocyte-macrophage colony-stimulating factor (GM-CSF) genes, the resulting virus is injected directly into the tumor, causing lysis and local immune responses secondary to the now GM-CSF-producing cells [104].